One test has a false positive rate of 93%.
on the astonishing number of false positives for these rare diseases, 81% of tests show a false positive for DiGeorge syndrome, which can cause heart defects and delayed language acquisition. For Prader-Willi syndrome, which can lead to seizures and an inability to control overeating, that false positive testing rate jumps to 93%.reported that these tests were inaccurate 85% of the time when it came to predicting the development of these rare conditions in the fetus.
Even if some were to wait and get a second diagnostic test with their OB-GYN, it would have to be further along in the pregnancy. In many states,confirm a condition, the pregnant person would be unable to terminate it if they wished.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
National Weather Service issues warning for beachgoers until late tonightThe affected area stretches from Monterey County to Sonoma County
Consulte Mais informação »
FDA Faces Push to Loosen Rules for Sperm DonationsThe FDA relaxed its rules regarding blood donation by men who have sex with men. Now the agency is being asked to change its sperm donation rules.
Consulte Mais informação »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Consulte Mais informação »
FDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Consulte Mais informação »
FDA approves first COVID-19 treatment for children under 12 years oldThe FDA gave approval to the use of Veklury (remdesivir) for children 28 days and older who weigh at least 3 kilograms (about 7 pounds).
Consulte Mais informação »
FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Consulte Mais informação »